2019 hallmark gene sets (Bioplanet)
86
Structured Review
Bioplanet
2019 hallmark gene sets
2019 Hallmark Gene Sets, supplied by Bioplanet, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2019+hallmark+gene+sets/2019+bioplanet+database/pm41422839-198-87-86
Average 86 stars, based on 1 article reviews
2019 Hallmark Gene Sets, supplied by Bioplanet, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2019+hallmark+gene+sets/2019+bioplanet+database/pm41422839-198-87-86
Average 86 stars, based on 1 article reviews
2019 hallmark gene sets - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Real-time Polymerase Chain Reaction:Article Title: Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer. Article Snippet: .. The top three downregulated genes are highlighted. (g) Semi-quantitative real-time PCR (sqRT PCR) of early growth response protein 1 (EGR1), fos proto-oncogene (FOS), and dual specificity phosphatase 6 (DUSP6) in mock (n = 8) and selumetinib-treated (n = 6) tumors, normalized to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and presented as 2^- ΔCq. (h, i) Pathway enrichment analysis of differentially expressed genes (DEGs, p < 0.05, fold change < -1.5) in mock (n = 6) and selumetinib-treated (n = 4) tumors using (h) Molecular Signature Database (MSigDB) and (i) BioPlanet Polymerase Chain Reaction:Article Title: Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer. Article Snippet: .. The top three downregulated genes are highlighted. (g) Semi-quantitative real-time PCR (sqRT PCR) of early growth response protein 1 (EGR1), fos proto-oncogene (FOS), and dual specificity phosphatase 6 (DUSP6) in mock (n = 8) and selumetinib-treated (n = 6) tumors, normalized to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and presented as 2^- ΔCq. (h, i) Pathway enrichment analysis of differentially expressed genes (DEGs, p < 0.05, fold change < -1.5) in mock (n = 6) and selumetinib-treated (n = 4) tumors using (h) Molecular Signature Database (MSigDB) and (i) BioPlanet |